U-ORMP

Q:ORMP - ORAMED PHARMACEUTICALS INC - https://www.oramed.com

20:07:22 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
ORMP - Q	0.1	3.11	·	3.45	0.1	3.41	+0.17	5.2	167.1	495	1,121	3.28 3.41 3.22	3.71 1.82	19:57:23	Jan 13	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 1121

More trades...

Time ET	Ex	Price	Change	Volume
19:57:23	Q	3.41	0.17	123
16:51:42	Q	3.41	0.17	6
16:10:04	Q	3.41	0.17	1
16:04:44	Q	3.41	0.17	1
16:04:40	Q	3.41	0.17	1
16:04:03	Q	3.41	0.17	1
16:04:02	Q	3.41	0.17	1
16:00:48	Q	3.41	0.17	1
16:00:17	Q	3.41	0.17	1
16:00:17	Q	3.41	0.17	1

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2026-01-13 08:00	U:ORMP	News Release200	Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
2026-01-13 07:58	U:ORMP	News Release200	Oramed and Lifeward Announce Strategic Transaction
2026-01-07 08:55	U:ORMP	News Release200	Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
2025-11-17 08:55	U:ORMP	News Release200	Oramed Reports Fiscal Third Quarter 2025 Financial Results
2025-11-17 08:50	U:ORMP	News Release200	ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
2025-10-23 08:55	U:ORMP	News Release200	Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
2025-04-28 09:00	U:ORMP	News Release200	Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
2025-04-28 09:00	U:ORMP	News Release200	Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
2025-03-04 09:00	U:ORMP	News Release200	Oramed Pharmaceuticals Issues Letter to Shareholders
2025-02-11 09:15	U:ORMP	News Release200	Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Date ET

Symbol

Type

Headline

2026-01-13 08:00

U:ORMP

News Release

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

2026-01-13 07:58

U:ORMP

News Release

Oramed and Lifeward Announce Strategic Transaction